Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 193 publications
Neutral Sphingomyelinase-2 Restrains TAZ to Suppress Breast Tumor Growth.
Journal: bioRxiv : the preprint server for biology
Published: May 25, 2026
Development of a FRET-Based Assay for Human Neutral Sphingomyelinase 2.
Journal: Biochemistry
Published: April 13, 2026
MECHANISMS OF DEOXYSPHINGANINE CYTOTOXICITY IN LYMPHOMA CELLS.
Journal: Journal of lipid research
Published: March 24, 2026
Triiodothyronine-driven pro-inflammatory responses of dendritic cells are restrained by sphingolipid signaling.
Journal: The Journal of endocrinology
Published: March 12, 2026
Steryl glucosides as a novel chemosensitizer: Enhancing doxorubicin response in estrogen receptor-positive breast cancer.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 02, 2026
Metabolic plasticity of sphingolipids governs cancer cell fitness in acidic tumor ecosystems.
Journal: bioRxiv : the preprint server for biology
Published: February 23, 2026
Metabolic plasticity of sphingolipids governs cancer cell fitness in acidic tumor ecosystems.
Journal: bioRxiv : the preprint server for biology
Published: February 23, 2026
A career in bioactive lipids.
Journal: The Journal of biological chemistry
Published: December 13, 2025
PKCα as a signaling gatekeeper upstream of mTORC1 in mEGFR NSCLC.
Journal: Advances in biological regulation
Published: October 13, 2025
Orm2 promotes nitrogen-induced sphingolipid production and endocytosis via Orm1 phosphorylation.
Journal: Journal of lipid research
Published: August 22, 2025
Retention of lysosomal acid sphingomyelinase protects from Niemann-Pick Disease.
Journal: Neurobiology of disease
Published: July 25, 2025
An integrative approach to studying sphingolipid metabolism reveals p53 as a master regulator of the pathway.
Journal: Journal of lipid research
Published: July 23, 2025
Last Updated: 09/26/2026